Life Science ApS: Financial statements 2022
CVR: 38453726
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Life Science ApS (CVR 38453726) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -733 and a net result of DKK -744 compared with DKK -1,963 the year before. Equity in the 2022 report amounted to DKK 14,862. The solvency ratio was 4.8%.
- Gross Profit
- DKK -733
- Profit/Loss
- DKK -744
- Equity
- DKK 14,862
- Total Assets
- DKK 308,910
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -733 | -744 | 15 t. | - |
| 2021 | - | -2 t. | -2 t. | 16 t. | - |
| 2020 | - | 0 | -3 | -21 t. | - |
| 2019 | - | -843 | -843 | -21 t. | - |
| 2018 | - | -25 t. | -22 t. | -21 t. | - |
Official annual report
Keep an eye on Life Science ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Life Science ApS has published its annual report for 2021. Gross profit came to DKK -1,956, and the net result was DKK -1,963.
About Life Science ApS
Life Science ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Life Science IVS and FluoGuide IVS. The management consists of Andreas Kjær and Morten Albrechtsen. The company is owned by Andreas Kjær and WEXOTEC ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,459 and a net result of DKK -11,456 compared with DKK -822 the year before. Equity in the 2025 report amounted to DKK 151,200.